Epidemiology of Idiopathic Central Serous Chorioretinopathy in Taiwan, 2001–2006: A Population-based Study

Objectives The epidemiology of idiopathic central serous chorioretinopathy (CSCR) is not well understood in an Asian population. The present study aimed to investigate the incidence and risk factors for corticosteroid-unrelated CSCR using Taiwan’s National Health Insurance Research Database. Methods and Results From 2001 to 2006, a total of 786 patients (500 [63.6%] males) who were newly diagnosed with CSCR, aged from 20 to 64 years and had no history of corticosteroid prescription were identified as incident cases of idiopathic CSCR. 3606 age-, gender-, and enrollment time-matched subjects were randomly selected as the control group. The mean annual incidence was 0.21‰ (0.27‰ for males, and 0.15‰ for females; P<0.001), with a male/female ratio of 1.74. The peak incidence was in the 35- to 39-year-old age group (0.30‰), followed by the 40- to 44-year-old age group (0.26‰). Males had a significantly higher mean annual incidence than female only in the middle age groups. Conditional logistic regression was used to estimate the odds ratios (ORs) for potential risk factors of idiopathic CSCR. Only exposure to anti-anxiety drugs (OR, 1.63; 95% confidence interval, 1.09–2.44) was found to be independently associated with idiopathic CSCR among males. No risk factors of idiopathic CSCR were found for females. Conclusions This study provides the nationwide, population-based data on the incidence of idiopathic CSCR in adult Asians, and suggests that exposure to anti-anxiety drugs is an independent risk factor for idiopathic CSCR among males.

[1]  Shih-Jen Chen,et al.  Increased risk of erectile dysfunction among males with central serous chorioretinopathy – a retrospective cohort study , 2013, Acta ophthalmologica.

[2]  Shih-Jen Chen,et al.  Central serous chorioretinopathy and risk of ischaemic stroke: a population-based cohort study , 2012, British Journal of Ophthalmology.

[3]  Yuh-Min Chen,et al.  Sleep apnea and risk of retinal vein occlusion: a nationwide population-based study of Taiwanese. , 2012, American journal of ophthalmology.

[4]  L. Yannuzzi TYPE-A BEHAVIOR AND CENTRAL SEROUS CHORIORETINOPATHY , 2012, Retina.

[5]  Frcs,et al.  Central Serous Chorioretinopathy , 2012 .

[6]  A. Lotery,et al.  Central serous chorioretinopathy: an update on pathogenesis and treatment , 2010, Eye.

[7]  Herng‐Ching Lin,et al.  Neovascular Age-Related Macular Degeneration and the Risk of Stroke: A 5-Year Population-Based Follow-Up Study , 2010, Stroke.

[8]  Retinal vein occlusion and the risk of acute myocardial infraction: a 3-year follow-up study , 2009, British Journal of Ophthalmology.

[9]  J. Pulido,et al.  The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002. , 2008, Ophthalmology.

[10]  R. Chervin,et al.  Central serous chorioretinopathy and risk for obstructive sleep apnea , 2007, Sleep and Breathing.

[11]  Y. Tano,et al.  Photodynamic Therapy in Macular Diseases of Asian Populations: When East Meets West , 2006, Japanese Journal of Ophthalmology.

[12]  E. Bouzas,et al.  Glucocorticoid use represents a risk factor for central serous chorioretinopathy: a prospective, case–control study , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.

[13]  D. Gagnon,et al.  Risk factors for central serous chorioretinopathy: a case-control study. , 2004, Ophthalmology.

[14]  P. Edwards,et al.  Central serous chorioretinopathy in African Americans. , 2003, Journal of the National Medical Association.

[15]  L. Yannuzzi,et al.  Corticosteroids and central serous chorioretinopathy. , 2002, Ophthalmology.

[16]  C. Pournaras,et al.  Central Serous Chorioretinopathy and Glucocorticoids , 2022 .

[17]  F. Geiser,et al.  Chorioretinopathia centralis serosa und psychische Belastung , 2000, Der Ophthalmologe.

[18]  J. Slakter,et al.  Systemic findings associated with central serous chorioretinopathy. , 1999, American journal of ophthalmology.

[19]  M. Wakakura,et al.  Corticosteroid-induced central serous chorioretinopathy. , 1997, Japanese journal of ophthalmology.

[20]  J. Slakter,et al.  Central serous chorioretinopathy in younger and older adults. , 1996, Ophthalmology.

[21]  T. Gardner,et al.  Central serous chorioretinopathy in women. , 1996, Ophthalmology.

[22]  M. Kaiser-Kupfer,et al.  Central serous chorioretinopathy in endogenous hypercortisolism. , 1993, Archives of ophthalmology.

[23]  C. Kirschbaum,et al.  Consistent sex differences in cortisol responses to psychological stress. , 1992, Psychosomatic medicine.

[24]  T. J. Harbin The relationship between the type A behavior pattern and physiological responsivity: a quantitative review. , 1989, Psychophysiology.

[25]  G. Gelber,et al.  Loss of vision due to central serous chorioretinopathy following psychological stress. , 1987, The American journal of psychiatry.

[26]  M. Wakakura,et al.  Central serous chorioretinopathy complicating systemic corticosteroid treatment. , 1984, The British journal of ophthalmology.

[27]  K. Fukunaga [Central chorioretinopathy with disharmony of the autonomous nerve system]. , 1969, Nippon Ganka Gakkai zasshi.